Device Week – June 20, 2016
This article was originally published in The Gray Sheet
On this week's podcast, we discussed cybersecurity, colorectal cancer screening guidelines, tax and patent legal rulings, and a busy week from FDA with rules and guidance documents.
You may also be interested in...
Financial ties between companies and healthcare bodies distort the production and use of evidence, claims a paper co-authored by researchers, clinicians and decision makers, including a representative of Germany’s HTA body, IQWiG.
Turku, Finland-based Forendo Pharma has entered into a license and collaboration deal with Novartis involving the identification of novel drugs to treat chronic liver diseases.
Three accelerated assessment requests will either be granted or rejected this week at the European Medicines Agency.